Csaba Tömböly
Csaba Tömböly
Head of the Laboratory of Chemical Biology, Biological Research Centre of the Hungarian Academy of Sciences
E-mail megerősítve itt: brc.hu
Cím
Hivatkozott rá
Hivatkozott rá
Év
In vitro quantitative study of the degradation of endomorphins
C Tömböly, A Péter, G Tóth
Peptides 23 (9), 1573-1580, 2002
1132002
Pain inhibition by endomorphins
R Przewłocki, D Łabuz, J Mika, B Przewłocka, C Tomboly, G Toth
Annals of the new York Academy of Sciences 897 (1), 154-164, 1999
1111999
Liquid chromatographic study of the enzymatic degradation of endomorphins, with identification by electrospray ionization mass spectrometry
A Péter, G Tóth, C Tömböly, G Laus, D Tourwè
Journal of Chromatography A 846 (1-2), 39-48, 1999
741999
Antinociceptive effects of intrathecal endomorphin-1 and-2 in rats
G Horvath, M Szikszay, C Tömböly, G Benedek
Life sciences 65 (24), 2635-2641, 1999
661999
In VitroBinding and Signaling Profile of the Novel μ Opioid Receptor Agonist Endomorphin 2 in Rat Brain Membranes
M Spetea, K Monory, C Tömböly, G Tóth, E Tzavara, S Benyhe, ...
Biochemical and biophysical research communications 250 (3), 720-725, 1998
611998
Specific activation of the μ opioid receptor (MOR) by endomorphin 1 and endomorphin 2
K Monory, MC Bourin, M Spetea, C Tömböly, G Tóth, HW Matthes, ...
European Journal of Neuroscience 12 (2), 577-584, 2000
602000
Structure− activity study on the Phe side chain arrangement of endomorphins using conformationally constrained analogues
C Tömböly, KE Kövér, A Péter, D Tourwé, D Biyashev, S Benyhe, ...
Journal of medicinal chemistry 47 (3), 735-743, 2004
522004
New endomorphin analogues containing alicyclic β-amino acids: Influence on bioactive conformation and pharmacological profile
A Keresztes, M Szucs, A Borics, KE Kövér, E Forro, F Fülöp, ...
Journal of medicinal chemistry 51 (14), 4270-4279, 2008
492008
Side chain modifications change the binding and agonist properties of endomorphin 2
I Lengyel, G Orosz, D Biyashev, L Kocsis, M Al-Khrasani, A Ronai, ...
Biochemical and biophysical research communications 290 (1), 153-161, 2002
442002
Endomorphin-1 and endomorphin-2 differentially interact with specific binding sites for substance P (SP) aminoterminal SP1–7 in the rat spinal cord
M Botros, M Hallberg, T Johansson, Q Zhou, G Lindeberg, PA Frändberg, ...
Peptides 27 (4), 753-759, 2006
432006
Endomorphin-2 with a β-turn backbone constraint retains the potent μ-opioid receptor agonist properties
C Tömböly, S Ballet, D Feytens, KE Kövér, A Borics, S Lovas, ...
Journal of medicinal chemistry 51 (1), 173-177, 2008
392008
Behavioral and neuroendocrine actions of endomorphin-2
E Bujdoso, M Jaszberenyi, C Tömböly, G Toth, G Telegdy
Peptides 22 (9), 1459-1463, 2001
382001
Influence of degradation on binding properties and biological activity of endomorphin 1
I Szatmári, D Biyashev, C Tömböly, G Tóth, M Mácsai, G Szabó, A Borsodi, ...
Biochemical and biophysical research communications 284 (3), 771-776, 2001
312001
Endomorphins interact with the substance P (SP) aminoterminal SP1–7 binding in the ventral tegmental area of the rat brain
M Botros, T Johansson, Q Zhou, G Lindeberg, C Tömböly, G Tóth, ...
Peptides 29 (10), 1820-1824, 2008
302008
New endomorphin analogs with mu-agonist and delta-antagonist properties
G Tóth, A Keresztes, C Tömböly, A Péter, F Fülöp, D Tourwé, ...
Pure and applied chemistry 76 (5), 951-957, 2004
282004
Preparation of specifically tritiated endomorphins
C Tömböly, R Dixit, I Lengyel, A Borsodi, G Tóth
Journal of Labelled Compounds and Radiopharmaceuticals: The Official Journal …, 2001
282001
Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration
R Perlikowska, J Piekielna, L Gentilucci, R De Marco, MC Cerlesi, G Calo, ...
European journal of medicinal chemistry 109, 276-286, 2016
242016
Effects of endomorphin-1 on open-field behavior and on the hypothalamic-pituitary-adrenal system
E Bujdosó, M Jászberényi, C Tömböly, G Tóth, G Telegdy
Endocrine 14 (2), 221-224, 2001
242001
Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors
A Mollica, S Pelliccia, V Famiglini, A Stefanucci, G Macedonio, ...
Journal of enzyme inhibition and medicinal chemistry 32 (1), 444-451, 2017
202017
Emotional disorders induced by Hemopressin and RVD-hemopressin (α) administration in rats
S Leone, L Recinella, A Chiavaroli, S Martinotti, C Ferrante, A Mollica, ...
Pharmacological Reports 69 (6), 1247-1253, 2017
192017
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20